Max Rosett, Chief Financial Officer at Immunome Inc. (IMNM), sold 60,000 shares at $18.23 ($1.1M) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($1.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |